Clinical Trial Update: Vitamin E and N-acetylcysteine for Preventing Contrast-Induced Acute Kidney Injury After Coronary Artery Catheterization [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update examining vitamin E and N-acetylcysteine for preventing contrast-induced acute kidney injury after coronary artery catheterization…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast-induced Nephropathy
• Coronary Angiography
• Coronary Artery Disease
• Coronary Syndrome
• Stable Angina

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)
• Vitamin E (tocopherol)

Snippet

Sponsor: Rajaie Cardiovascular Medical and Research Center | Conditions: Coronary Artery Disease, Coronary Artery Angiography | Phase 3 | Status: UNKNOWN